The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Novel anti-EGFRvIII bispecific T cell engager (BiTE) antibody construct in glioblastoma (GBM): Trial in progress of AMG 596 in patients with recurrent or newly diagnosed disease.
 
Mark Rosenthal
No Relationships to Disclose
 
Carmen Balana
Consulting or Advisory Role - Abbvie; Celgene
Travel, Accommodations, Expenses - Abbvie; Pfizer; Pfizer; SERVIER
 
Myra Ellen Van Linde
No Relationships to Disclose
 
Cyrus Sayehli
Honoraria - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene
 
Walter M. Fiedler
Consulting or Advisory Role - Amgen; ARIAD; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Amgen
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo; Jazz Pharmaceuticals
 
Martin Wermke
Honoraria - Bristol-Myers Squibb; Kite, a Gilead company; Merck; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Kite, a Gilead company; Novartis
Travel, Accommodations, Expenses - Glenmark
 
Christophe Massard
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Celgene; Debiopharm Group; Genentech; Ipsen; Janssen; Lilly; MedImmune; MSD; Novartis; Orion; Pfizer; Roche; Sanofi
Other Relationship - Abbvie; Aduro Biotech; Agios; Amgen; arGEN-X BVBA; Astex Pharmaceuticals; AstraZeneca; AVEO; Bayer; BeiGene; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Chugai Pharma; Clovis Oncology; Daiichi Sankyo; Debiopharm Group; Eisai; Exelixis; FORMA Therapeutics; GamaMabs Pharma; Genentech; GlaxoSmithKline; Gortec; H3 biomedecine; Incyte; Innate Pharma; ITeos Therapeutics; Janssen; Kura Oncology; Kyowa Hakko Kirin; Lilly; Loxo; Lytix Biopharma; Medimmune; Menarini; Merus; MSD; Nanobiotix; Nektar; Novartis; Octimet; Oncoethix; Oncopeptides; Orion; Pfizer; Pharmamar; Pierre Fabre; Roche; Sanofi; Servier; Sierra Oncology; Taiho Pharmaceutical; Takeda; Tesaro; The Lymphoma Academic Research Organization; Xencor
 
Agnes Ang
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Patents, Royalties, Other Intellectual Property - Amgen
Travel, Accommodations, Expenses - Amgen
 
Johannes Kast
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Travel, Accommodations, Expenses - Abbvie; Genentech
 
Sabine Stienen
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Patents, Royalties, Other Intellectual Property - Amgen
 
Timothy Francis Cloughesy
Stock and Other Ownership Interests - Notable Labs
Consulting or Advisory Role - Abbvie; Agios; Alexion Pharmaceuticals; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Celgene; cortice; Deciphera; Genocea Biosciences; GW Pharmaceuticals; Human Longevity, Inc; Insys Therapeutics; KIYATEC; Lilly; Merck; NewGen Therapeutics; Notable Labs; Novartis; Novocure; Novogen; Oxigene; Pfizer; Puma Biotechnology; Roche/Genentech; Sunovion; Tocagen; VBI Vaccines; VBL Therapeutics; wellcome trust
Other Relationship - Global Coalition for Adaptive Research